Form 4: Biodesix Executive Kieran O'Kane Reports Stock Transactions
SEC Form 4 Filing
Chief Commercial Officer Kieran O'Kane reports acquisition and disposal of Biodesix Inc. stock, including shares sold to cover taxes upon RSU vesting.
Summary
- Kieran O'Kane, Chief Commercial Officer of Biodesix Inc. (BDSX), filed a Form 4 detailing changes in beneficial ownership.
- On May 8, 2024, O'Kane acquired 1,489 shares of common stock through the vesting of Restricted Stock Units (RSUs).
- Also on May 8, 2024, 1,489 Restricted Stock Units vested.
- On May 9, 2024, O'Kane disposed of 468 shares of common stock at a price of $1.4795 per share.
- The sale on May 9th was automatically executed to cover taxes upon the vesting of RSUs.
- Following these transactions, O'Kane beneficially owns 75,524 shares of Biodesix Inc. common stock.
- The RSUs vest in sixteen quarterly installments from February 8, 2022.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge executive sentiment and potential future stock performance.
Comparison to Industry Standards
- Executive compensation packages often include RSUs that vest over time, aligning executive interests with long-term shareholder value.
- Selling shares to cover taxes upon vesting of RSUs is a common practice among executives.
- The weighted average price of $1.4795 is within the range of $1.43 to $1.53, which is typical for market fluctuations.
Stakeholder Impact
- Shareholders are informed about the insider trading activity of a key executive.
- The transactions have a minimal impact on the overall stock price due to the relatively small volume of shares involved.
Key Dates
| Date | Description |
|---|---|
| 2022/02/08 | Date from which RSUs vest in sixteen successive quarterly installments. |
| 2024/02/09 | Date of shares that were inadvertently reported as being sold in a previous Form 4 filing. |
| 2024/02/12 | Date of previous Form 4 filing that inadvertently reported shares as being sold. |
| 2024/02/29 | Date of shares purchased under the Issuer's Employee Stock Purchase Plan. |
| 2024/05/08 | Date of RSU vesting and acquisition of 1,489 shares. |
| 2024/05/09 | Date of sale of 468 shares to cover taxes. |
| 2024/05/10 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.